Nasdaq has approved the listing of the Injective ETF with staking functionality from Canary Capital.
The product is described as an exchange-traded fund for the Injective (INJ) asset with staking capabilities. Canary Capital is the issuer. The announcement does not disclose further details or the fund's structure.
A linked document with additional information is available to the public: document.
